Perikard Hastalıkları

References (15)

1. Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, et al. American Heart Association
2. Council on Clinical Cardiology, Heart Failure and Transplantation Committee
3. Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups
4. Council on Epidemiology and Prevention. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee
5. Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups
6. and Council on Epidemiology and Prevention. Circulation 2006
7. [CrossRef] O'Donnell DH, Abbara S, Chaithiraphan V, Yared K, Killeen RP, Martos R, et al. Cardiac MR Imaging of Nonischemic Cardiomyopathies: Imaging Protocols and Spectra of Appearances. Radiology 2015
8. [CrossRef] Fontana M, Banypersad SM, Treibel TA, Abdel-Gadir A, Maestrini V, Lane T, et al. Differential myocyte responses in patients with cardiac transthyretin amyloidosis and light-chain amyloidosis: a cardiac MR imaging study. Radiology 2015
9. [CrossRef] Pozo E, Kanwar A, Deochand R, Castellano JM, Naib T, Pazos-López P, et al. Cardiac magnetic resonance evaluation of left ventricular remodelling distribution in cardiac amyloidosis. Heart 2014
10. [CrossRef] Raina S, Lensing SY, Nairoozz RS, Pothineni NV, Hakeem A, Bhatti S, et al. Prognostic Value of Late Gadolinium Enhancement CMR in Systemic Amyloidosis. JACC Cardiovasc Imaging 2016
11. [CrossRef] Vogelsberg H, Mahrholdt H, Deluigi CC, Yilmaz A, Kispert EM, Greulich S, et al. Cardiovascular magnetic resonancein clinically suspected cardiac amyloidosis: noninvasive imaging compared toendomyocardial biopsy. J Am Coll Cardiol 2008
12. [CrossRef] Baksi AJ, Pennell DJ. T2* Imaging of the Heart Methods, Applications, and Outcomes. Top Magn Reson Imaging 2014
13. [CrossRef] Anderson LJ, Holden S, Davies B, Prescott E, Charrier CC, Bunce NH, et al. Cardiovascular T2* magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 2001
14. [CrossRef] Wood JC, Tyszka JM, Carson S, Nelson MD, Coates TD. Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease. Blood 2004
15. [CrossRef] Srinivasan G, Joseph M, Selvanayagam JB. Recent advances in the ima